SU

Santosh Uttam Sawane

Active Director Director DIN 09397455
DIN 09397455 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Uttam Sawane

Data last updated:

Santosh Uttam Sawane is a Director at Padmasri Nursing's Home & Reaserrch Private Limited (since 2021). The company operates in Healthcare.

DIN 09397455
Primary Designation Director
Industry Healthcare
First Appointment 12 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Nov 20212021Active

Directorship timeline

Open interactive timeline →
Padmasri Nursing's Home & Reaserrch Private Limited
Premium access

Shareholding and investment profile for Santosh Uttam Sawane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Uttam Sawane

Santosh Uttam Sawane currently holds 1 directorship: Padmasri Nursing's Home & Reaserrch Private Limited (Director, since 12 Nov 2021).

Santosh Uttam Sawane was first appointed on 12 Nov 2021 as Director at Padmasri Nursing's Home & Reaserrch Private Limited.

The current boards of Santosh Uttam Sawane's companies include Deepak Sopan Kuchekar (Padmasri Nursing's Home & Reaserrch Private Limited), Manisha Deepak Kuchekar (Padmasri Nursing's Home & Reaserrch Private Limited), Monal Santosh Sawane (Padmasri Nursing's Home & Reaserrch Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available